Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes

References

• Mihic SJ, Mayfield J, Harris RA. Hypnotics and sedatives. In: Brunton LL, Hilal-Dandan R, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 13 ed. McGraw-Hill Education; 2017.
   Google Scholar
• Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Eur Neuropsychopharmacol. 1999;9:S399–S405. doi:10.1016/S0924-977X(99)00051-610622686
   PubMed Web of Science ®Google Scholar
• Hollingworth SA, Siskind DJ. Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiol Drug Saf. 2010;19(3):280–288. doi:10.1002/pds.189920073039
   PubMed Web of Science ®Google Scholar
• Hwang SH, Han S, Choi H, Park C, Kim SM, Kim TH. Trends in the prescription of benzodiazepines for the elderly in Korea. BMC Psychiatry. 2017;17(1):303. doi:10.1186/s12888-017-1467-z28830488
   PubMed Web of Science ®Google Scholar
• Li C, Santaella-Tenorio J, Mauro PM, Martins SS. Past-year use of prescription opioids and/or benzodiazepines among adults in the United States: estimating medical and nonmedical use in 2015–2016. Drug Alcohol Depend. 2019;204:107458. doi:10.1016/j.drugalcdep.2019.04.02931494445
   PubMed Web of Science ®Google Scholar
• Tardelli VS, Fidalgo TM, Santaella J, Martins SS. Medical use, non-medical use and use disorders of benzodiazepines and prescription opioids in adults: differences by insurance status. Drug Alcohol Depend. 2019;204:107573. doi:10.1016/j.drugalcdep.2019.10757331568936
   PubMed Web of Science ®Google Scholar
• Schweizerische Fachgesellschaft für Geriatrie [homepage on the Internet]. Bern: Benzodiazepine nur in Ausnahmefällen [Benzodiazepines only in exceptional cases]. Smarter medicine - choosing wisely Switzerland. Available from: https://www.smartermedicine.ch/de/datensammlung/detail/empfehlung/fachperson/17.html. Accessed 530, 2020. German.
   Google Scholar
• By the 2019 American Society Beers Criteria® Update Expert Panel. American geriatrics society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694. doi:10.1111/jgs.1576730693946
   PubMed Web of Science ®Google Scholar
• Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700. doi:10.1111/jsr.1259428875581
   PubMed Web of Science ®Google Scholar
• Murrough JW, Yaqubi S, Sayed S, Charney DS. Emerging drugs for the treatment of anxiety. Expert Opin Emerg Drugs. 2015;20(3):393–406. doi:10.1517/14728214.2015.104999626012843
   PubMed Web of Science ®Google Scholar
• Olfson M, King M, Schoenbaum M. Benzodiazepine Use in the United States. JAMA Psychiatry. 2015;72(2):136–142. doi:10.1001/jamapsychiatry.2014.176325517224
   PubMed Web of Science ®Google Scholar
• Akpinar A, Yaman AR, Karakuş K, Atay I, Demirci K. The frequency of benzodiazepine use in the Isparta Province. Klinik Psikofarmakol Bülteni. 2016;26(2):169–174. doi:10.5455/bcp.20150707103818
   Google Scholar
• Préville M, Bossé C, Vasiliadis HM, et al. Correlates of potentially inappropriate prescriptions of benzodiazepines among older adults: results from the ESA study. Can J Aging. 2012;31(3):313–322. doi:10.1017/S071498081200023222800936
   PubMed Web of Science ®Google Scholar
• Luta X, Bagnoud C, Lambiris M, et al. Patterns of benzodiazepine prescription among older adults in Switzerland: a cross-sectional analysis of claims data. BMJ Open. 2020;10(1):e031156. doi:10.1136/bmjopen-2019-031156
   PubMed Web of Science ®Google Scholar
• Petitjean S, Ladewig D, Meier CR, Amrein R, Wiesbeck GA. Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies. Int Clin Psychopharmacol. 2007;22(5):292–298. doi:10.1097/YIC.0b013e328105e0f217690598
   PubMed Web of Science ®Google Scholar
• Gmel G, Kuendig H, Maffli E, et al. Suchtmonitoring Schweiz/Jahresbericht [addiction monitoring Switzerland/annual report]. - daten 2011, Bern 2012. Schweiz, German.
   Google Scholar
• Gmel G, Notari L, Gmel C. Suchtmonitoring Schweiz–Einnahme von psychoaktiven und anderen Medikamenten in der Schweiz im Jahr 2012 [addiction monitoring Switzerland – Use of psychoactive and other drugs in Switzerland in 2012]. Sucht Schweiz, Lausanne. Schweiz, German; 2013.
   Google Scholar
• Gmel G, Notari L, Gmel C. Suchtmonitoring Schweiz–Vertiefende Analysen zur Einnahme von Schlafmitteln, Beruhigungsmitteln sowie Psychostimulanzien im Jahr 2014 [addiction monitoring Switzerland - in-depth analyses of the use of sleeping pills, tranquilizers and psychostimulants in 2014]. Sucht Schweiz, Lausanne. Schweiz, German; 2015.
   Google Scholar
• Gmel G, Notari L, Gmel C. Suchtmonitoring Schweiz–Einnahme von psychoaktiven Medikamenten in der Schweiz im Jahr 2015 [addiction monitoring Switzerland – Intake of psychoactive drugs in Switzerland in 2015]. Sucht Schweiz, Lausanne. Schweiz, German; 2016.
   Google Scholar
• Gmel G, Notari L, Gmel C. Suchtmonitoring Schweiz–Einnahme von psychoaktiven Medikamenten in der Schweiz im Jahr 2016 [addiction monitoring Switzerland – Intake of psychoactive drugs in Switzerland in 2016]. Sucht Schweiz, Lausanne. Schweiz, German; 2018.
   Google Scholar
• Bierman EJM, Comijs HC, Gundy CM, Sonnenberg C, Jonker C, Beekman ATF. The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent? Int J Geriatr Psychiatry. 2007;22(12):1194–1200. doi:10.1002/gps.181117407168
   PubMed Web of Science ®Google Scholar
• Wu C-S, Wang S-C, Chang IS, Lin K-M. The association between dementia and long-term use of benzodiazepine in the elderly: nested case–control study using claims data. Am J Geriatr Psychiatry. 2009;17(7):614–620. doi:10.1097/JGP.0b013e3181a6521019546656
   PubMed Web of Science ®Google Scholar
• Gomm W, von Holt K, Thomé F, et al. Regular benzodiazepine and Z-substance use and risk of dementia: an analysis of German claims data. J Alzheimers Dis. 2016;54(2):801–808. doi:10.3233/JAD-15100627567804
   PubMed Web of Science ®Google Scholar
• Billioti de Gage S, Bégaud B, Bazin F. Benzodiazepine use and risk of dementia: prospective population based study. BMJ. 2012;345:e6231–e6231. doi:10.1136/bmj.e623123045258
   PubMed Web of Science ®Google Scholar
• Islam MM, Iqbal U, Walther B, et al. Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology. 2016;47(3–4):181–191. doi:10.1159/00045488128013304
   PubMed Web of Science ®Google Scholar
• Schroeck JL, Ford J, Conway EL, et al. Review of safety and efficacy of sleep medicines in older adults. Clin Ther. 2016;38(11):2340–2372. doi:10.1016/j.clinthera.2016.09.01027751669
   PubMed Web of Science ®Google Scholar
• Yu N-W, Chen P-J, Tsai H-J, et al. Association of benzodiazepine and Z-drug use with the risk of hospitalisation for fall-related injuries among older people: a nationwide nested case-control study in Taiwan. BMC Geriatr. 2017;17(1):140. doi:10.1186/s12877-017-0530-428693443
   PubMed Web of Science ®Google Scholar
• Nakao M, Sato M, Nomura K, Yano E. Benzodiazepine prescription and length of hospital stay at a Japanese university hospital. Biopsychosoc Med. 2009;3(1):10. doi:10.1186/1751-0759-3-1019818119
   PubMedGoogle Scholar
• WHO. Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC Classification and DDD Assignment, 2020. Oslo; 2019.
   Google Scholar
• Ashton H. (2002) [homepage on the Internet]. Benzodiazepines: how they work and how to withdraw. The Ashton Manual. Newcastle upon Tyne, England, UK: New Castle University; 2002. Available from: https://benzo.org.uk/index.htm. Accessed 613, 2020.
   Google Scholar
• Bundesamt für Statistik (2019) [homepage on the Internet]. Raumgliederung der Schweiz [regional division of Switzerland]. Gemeindetypologie und Stadt/Land-Typologie; 2019. Available from: https://www.bfs.admin.ch/bfs/de/home/grundlagen/raumgliederungen.assetdetail.9046166.html2019. Accessed 530, 2020. German.
   Google Scholar
• Huber CA, Szucs TD, Rapold R, Reich O. Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications. BMC Public Health. 2013;13(1):1030. doi:10.1186/1471-2458-13-103024172142
   PubMed Web of Science ®Google Scholar
• Lagnaoui R, Depont F, Fourrier-Réglat A, et al. Patterns and correlates of benzodiazepine use in the French general population. Eur J Clin Pharmacol. 2004;60(7):523–529. doi:10.1007/s00228-004-0808-215338086
   PubMed Web of Science ®Google Scholar
• Donato F, Samani F, Marini M, et al. Across-sectional survey on benzodiazepine use among older people in an Italian region. Ital J Public Health. 2005;2.
   Google Scholar
• Egan M, Moride Y, Wolfson C, Monette J. Long-term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors. J Am Geriatr Soc. 2000;48(7):811–816. doi:10.1111/j.1532-5415.2000.tb04758.x10894322
   PubMed Web of Science ®Google Scholar
• Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996–2013. Am J Public Health. 2016;106(4):686–688. doi:10.2105/AJPH.2016.30306126890165
   PubMed Web of Science ®Google Scholar
• Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl. 2010;107(131–132):543.
   Google Scholar
• Verthein U, Buth S, Holzbach R, Neumann-Runde E, Martens MS. Benzodiazepine und Z-substanzen - Analyse der kassenärztlichen Verschreibungen von 2006 bis 2015. Psychiatr Prax. 2019;46(7):399–405. doi:10.1055/a-0961-237131412372
   PubMed Web of Science ®Google Scholar
• Sonnenberg CM, Bierman EJ, Deeg DJ, Comijs HC, van Tilburg W, Beekman AT. Ten-year trends in benzodiazepine use in the Dutch population. Soc Psychiatry Psychiatr Epidemiol. 2012;47(2):293–301. doi:10.1007/s00127-011-0344-121258999
   PubMed Web of Science ®Google Scholar
• Kassam A, Patten SB. Hypnotic use in a population-based sample of over thirty-five thousand interviewed Canadians. Popul Health Metr. 2006;4(1):15. doi:10.1186/1478-7954-4-1517125509
   PubMedGoogle Scholar
• Fourrier-Réglat A, Letenneur L, Dartigues J, Moore N, Begaud B. Benzodiazepine use in an elderly community-dwelling population. Eur J Clin Pharmacol. 2001;57(5):419–425. doi:10.1007/s00228010032611599660
   PubMed Web of Science ®Google Scholar
• Nowakowski S, Meliska CJ, Fernando Martinez L, Parry BL. Sleep and menopause. Curr Neurol Neurosci Rep. 2009;9(2):165–172. doi:10.1007/s11910-009-0025-619268040
   PubMed Web of Science ®Google Scholar
• Susukida R, Mojtabai R, Mendelson T. Sex differences in help seeking for mood and anxiety disorders in the national comorbidity survey-replication. Depress Anxiety. 2015;32(11):32. doi:10.1002/da.2236625585535
   PubMed Web of Science ®Google Scholar
• Cascade E, Kalali AH. Use of benzodiazepines in the treatment of anxiety. Psychiatry. 2008;5(9):21–22.19727256
   PubMedGoogle Scholar
• Jacob L, Rapp MA, Kostev K. Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis. Ther Adv Psychopharmacol. 2017;7(6–7):191–200. doi:10.1177/204512531769645428740636
   PubMed Web of Science ®Google Scholar
• Neutel C. The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry. 2005;17(3):189–197. doi:10.1080/0954026050007186316194790
   PubMed Web of Science ®Google Scholar
• Ong MS, Olson KL, Cami A, et al. Provider patient-sharing networks and multiple-provider prescribing of benzodiazepines. Int J Gen Med. 2016;31(2):164–171. doi:10.1007/s11606-015-3470-8
   Web of Science ®Google Scholar
• Worley J, Hall JM. Doctor shopping: a concept analysis. Res Theory Nurs Pract. 2012;26(4):pp. 262–278. doi:10.1891/1541-6577.26.4.262
   Web of Science ®Google Scholar
• Cook J, Marshall R, Masci C, Coyne J. Physicians’ perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med. 2007;22(3):303–307. doi:10.1007/s11606-006-0021-317356959
   PubMed Web of Science ®Google Scholar
• Cook J, Biyanova T, Masci C, Coyne J. Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study. J Gen Intern Med. 2007;22(8):1094–1100. doi:10.1007/s11606-007-0205-517492325
   PubMed Web of Science ®Google Scholar
• Everitt H, McDermott L, Leydon G, Yules H, Baldwin D, Little P. GPs’ management strategies for patients with insomnia: a survey and qualitative interview study. Br J Gen Pract. 2014;64(619):e112–9. doi:10.3399/bjgp14X67717624567616
   PubMed Web of Science ®Google Scholar
• Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf. 2004;3(5):485–493. doi:10.1517/14740338.3.5.48515335303
   PubMedGoogle Scholar
• Alvarenga J, Loyola Filho A, Firmo J, Lima-Costa M, Uchoa E. A population based study on health conditions associated with the use of benzodiazepines among older adults (The Bambui health and aging study). Cad Saude Publica. 2009;25:605–612. doi:10.1590/S0102-311X200900030001519300849
   PubMed Web of Science ®Google Scholar
• Kroll D, Reyes Nieva H, Barsky A, Linder J. Benzodiazepines are prescribed more frequently to patients already at risk for benzodiazepine-related adverse events in primary care. J Gen Intern Med. 2016;31(9):31. doi:10.1007/s11606-016-3740-0
   Web of Science ®Google Scholar
• Scholz I, Schmid Y, Exadaktylos A, Haschke M, Liechti M, Liakoni E. Emergency department presentations related to abuse of prescription and over-the-counter drugs in Switzerland: time trends, sex and age distribution. Swiss Med Wkly. 2019;149:149. doi:10.4414/smw.2019.20056
   Web of Science ®Google Scholar
• Frey D, Ortega J, Wiseman C, Farley C, Wright K. Influence of zolpidem and sleep inertia on balance and cognition during nighttime awakening: a randomized placebo-controlled trial. J Am Geriatr Soc. 2011;59(1):73–81. doi:10.1111/j.1532-5415.2010.03229.x21226678
   PubMed Web of Science ®Google Scholar
• Finkle W, Der J, Greenland S, et al. Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc. 2011;59(10):1883–1890. doi:10.1111/j.1532-5415.2011.03591.x22091502
   PubMed Web of Science ®Google Scholar
• Lai -M-M, Lin -C-C, Lin -C-C, Liu C-S, Li T-C, Kao C-H. Long-term use of zolpidem increases the risk of major injury: a population-based cohort study. Mayo Clin Proc. 2014;89(5):89. doi:10.1016/j.mayocp.2014.01.021
   Web of Science ®Google Scholar
• Markota M, Rummans TA, Bostwick JM, Lapid MI. Benzodiazepine use in older adults: dangers, management, and alternative therapies. Mayo Clin Proc. 2016;91(11):1632–1639. doi:10.1016/j.mayocp.2016.07.02427814838
   PubMed Web of Science ®Google Scholar
• Imfeld P, Bodmer M, Jick SS, Meier CR. Benzodiazepine use and risk of developing alzheimer’s disease or vascular dementia: a case–control analysis. Drug Saf. 2015;38(10):909–919. doi:10.1007/s40264-015-0319-326123874
   PubMed Web of Science ®Google Scholar
• Biétry FA, Pfeil AM, Reich O, Schwenkglenks M, Meier CR. Benzodiazepine use and risk of developing alzheimer’s disease: a case-control study based on Swiss claims data. CNS Drugs. 2017;31(3):245–251. doi:10.1007/s40263-016-0404-x28078633
   PubMed Web of Science ®Google Scholar
• Billioti de Gage S, Moride Y, Ducruet T. Benzodiazepine use and risk of Alzheimer’s disease: case-control study. BMJ. 2014;349:g5205–g5205. doi:10.1136/bmj.g520525208536
   PubMed Web of Science ®Google Scholar
• Panes A, Fourrier-Réglat A, Verdoux H, Tournier M. Usages et mésusages des benzodiazépines chez les patients souffrant de troubles psychiatriques [Use and misuse of benzodiazepines in patients with psychiatric disorders]. Presse Med. 2018;47(10):886–891. doi:10.1016/j.lpm.2018.10.00330454581
   PubMed Web of Science ®Google Scholar
• Sidorchuk AA-O, Isomura K, Molero YA-O, et al. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: a total population register-linkage study. PLoS Med. 2018;15(8):e1002635. doi:10.1371/journal.pmed.100263530086134
   PubMed Web of Science ®Google Scholar
• Wolitzky-Taylor KB, Castriotta N, Lenze EJ, Stanley MA, Craske MG. Anxiety disorders in older adults: a comprehensive review. Depress Anxiety. 2010;27(2):190–211. doi:10.1002/da.2065320099273
   PubMed Web of Science ®Google Scholar